Patents by Inventor Simon Schenk

Simon Schenk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutrients to enhance load-induced muscle hypertrophy
    Patent number: 11312695
    Abstract: Methods and compositions are provided for increasing muscle hypertrophy, e.g., through the administration of novel combinations of natural products that inhibit SIRT1.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: April 26, 2022
    Assignees: The Regents of the University of California, University of Birmingham
    Inventors: Keith Baar, Andrew Philp, Simon Schenk
  • NOVEL NUTRIENTS TO ENHANCE LOAD-INDUCED MUSCLE HYPERTROPHY
    Publication number: 20210214329
    Abstract: Methods and compositions are provided for increasing muscle hypertrophy, e.g., through the administration of novel combinations of natural products that inhibit SIRT1.
    Type: Application
    Filed: February 23, 2021
    Publication date: July 15, 2021
    Inventors: Keith Baar, Andrew Philp, Simon Schenk
  • Method for increasing muscle growth by blocking sirtuin activity
    Patent number: 9480675
    Abstract: Systems and methods are described providing therapeutic preparations of sirtuin inhibitors, such as SIRT1 inhibitors, for stimulating load-induced skeletal muscle growth in the body of a patient. The natural stimulation of SIRT1 activity can be suppressed through increased caloric intake and loading in conjunction with the inhibition of sirtuin activity to improve the inhibitory effect. In addition, known muscle growth promoting agents such as amino acids and hormones can be administered at the same time as the sirtuin inhibitor. The size of the tissue structure to be treated or the body size may be used to determine the therapeutic dose of sirtuin inhibitor. The sirtuin inhibitor and muscle stimulating agents are either locally or systemically delivered at therapeutic doses for the desired effect. The SIRT1 inhibitor Splitomycin is particularly effective.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: November 1, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Andrew Philp, Simon Schenk, Keith Baar
  • METHOD FOR INCREASING MUSCLE GROWTH BY BLOCKING SIRTUIN ACTIVITY
    Publication number: 20160000752
    Abstract: Systems and methods are described providing therapeutic preparations of sirtuin inhibitors, such as SIRT1 inhibitors, for stimulating load-induced skeletal muscle growth in the body of a patient. The natural stimulation of SIRT1 activity can be suppressed through increased caloric intake and loading in conjunction with the inhibition of sirtuin activity to improve the inhibitory effect. In addition, known muscle growth promoting agents such as amino acids and hormones can be administered at the same time as the sirtuin inhibitor. The size of the tissue structure to be treated or the body size may be used to determine the therapeutic dose of sirtuin inhibitor. The sirtuin inhibitor and muscle stimulating agents are either locally or systemically delivered at therapeutic doses for the desired effect. The SIRT1 inhibitor Splitomycin is particularly effective.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 7, 2016
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Andrew Philp, Simon Schenk, Keith Baar